Press release from Humboldt County COVID19 – Joint Information Center: Humboldt County’s total COVID-19 case count rose to 217, as 12 additional cases have been reported. While this is the largest single-day increase since the outbreak began, today’s report includes all new cases since Friday’s report. Since last Monday’s update of case distribution by age,…
Japan's Government Pension Investment Fund lost 11%, or $164.7 billion, in the three months ended March, it said in Tokyo on Friday.The results come just months after the fund revamped top management and revised its asset allocation to focus more on overseas debt.Overseas bonds were the only major asset to generate a positive quarterly return.The…
Children and teenagers represent the fastest-growing age groups hit by the COVID-19 pandemic, according to new data released Friday by the Minnesota Department of Health that included 5 more deaths and 498 more lab-confirmed cases of the infectious disease. The number of lab-confirmed cases in Minnesota has increased 37% — from 25,208 on June 1…
Hale Nani Rehabilitation and Nursing Center has confirmed a small outbreak at the state’s largest nursing home with at least four residents and one staff member now testing positive for the coronavirus. The company confirmed the news in a letter posted on the website of its parent company Avalon Health Care Group. “Despite our best…
SALT LAKE CITY — Utah officials on Friday confirmed the largest daily rise in COVID-19 cases since the outbreak began, with 343 cases added since Thursday. Those new cases bring the Beehive State’s total since the outbreak began to 9,264, according to the Utah Department of Health. Just over 2,300 more people were tested, of…
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.
You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f